Top Section/Ad
Top Section/Ad
Most recent
Offer came as markets recovered and volatility fell
Abbott Laboratories plundered $20bn as it led a trio of drug companies which printed jumbo bonds as a deluge of supply in the dollar market ensured a red-hot end to the month.
Eight banks provided loan facility to company
More articles/Ad
More articles/Ad
More articles
-
Long delayed listing of Nestlé's former skincare division is finally underway -
LivaNova and MicroStrategy ride US tech convertible wave as maturity wall pushes issuers to refinance
-
Bankers hopeful more supply will follow, but no pipeline forthcoming
-
The strong market conditions are tempting cash rich issuers
-
Three borrowers head to euros to fund M&A activity
-
US corporate bond market jumping with deals despite inflation shock on Tuesday
